|

TNF Inhibitor (W12-W48) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • University Hospital, Montpellier1

Indications

  • Arthritis1
  • Rheumatoid Arthritis1

Other1 trial

Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.